MedTrace Logo

Three-Dimensional Molds Based on Radiological imagEs in Patients With Cancer: the DIRECT Trial

NCT07778173 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-21

No results posted yet for this study

Summary

Determination of the sites from which the histopathological samples in surgically removed lesions are collected is still done by eye by a pathologist. As radiological determination of regions of interest has already proven useful in in vivo use cases, the implementation of sampling of ex vivo lesions with the help of radiological imaging suggests great potential. By developing and implementing mold printing processes, these molds have the potential to vastly improve the accuracy and consistency of histopathological sampling and collection of tissue samples from different regions of tumor, leading to improved characterization, more individualized treatments, and eventually better survival.

Conditions

Interventions

PROCEDURE

3D-printed tumor mold for tissue sampling

3D-printed tumor mold for tissue sampling

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • Kuopio University Hospital

    collaborator OTHER

  • University of Eastern Finland

    collaborator OTHER

  • Tampere University Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2033-12-31
Completion
2033-12-15

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07778173 on ClinicalTrials.gov